| AST (n = 26) |  |  | Placebo (n = 25) |  |  |  |
---|---|---|---|---|---|---|---|
Variables | Pre-intervention serum levels | Post-intervention serum levels | Paired P-value | Pre-intervention serum levels | Post-intervention serum levels | Paired P-value | P-value between groups |
SOD (U/ml) | 14.97 ± 2.26 | 16.26 ± 2.22 | 0.013* | 15.28 ± 2.01 | 14.59 ± 3.59 | 0.351 | 0.027* |
TAC (µmol/L) | 892.50 ± 81.77 | 910.05 ± 92.56 | 0.030* | 918.73 ± 127.35 | 889.06 ± 203.20 | 0.468 | 0.246 |
MDA (µmol/L) | 16.82 ± 1.22 | 16.19 ± 1.27 | 0.005* | 16.74 ± 1.44 | 16.43 ± 1.64 | 0.135 | 0.261 |
Il-6 (pg/ml) | 1.74 ± 0.33 | 1.25 ± 0.32 | 0.000* | 1.61 ± 0.33 | 1.67 ± 0.30 | 0.098 | 0.000* |
Il-8 (pg/ml) | 14.62 ± 1.87 | 13.38 ± 1.65 | 0.001* | 14.58 ± 2.22 | 14.28 ± 2.55 | 0.323 | 0.035* |
VEGF (pg/ml) | 13.20 ± 2.96 | 12.37 ± 2.87 | 0.002* | 12.71 ± 3.19 | 12.43 ± 3.20 | 0.123 | 0.071 |